// App-Quantinova.ai

e15090 : A review of the patterns of prescribing, efficacy and toxicities for patients receiving checkpoint inhibitors.

Researchers

Presenter

  • Peter Nightingale

Principal Investigators

  • Phillip Parente

Medical Centers

  • Eastern Health, Mont Albert, Australia

  • Monash University Eastern Health Clinical School, Melbourne, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved